FEVERTREE DRINKS PLC — Regulatory Filings 2019

Apr 23, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7600W

Fevertree Drinks PLC

23 April 2019

23rd April 2019

Fevertree Drinks plc

("Fever-Tree" or the "Company")

2018 Annual Report and Notice of Annual General Meeting

Fever-Tree, the world's leading supplier of premium carbonated mixers, has posted its 2018 Annual Report and Notice of 2018 Annual General Meeting to shareholders.

The 2018 Annual Report is now available to view on the Company's website at www.fever-tree.com/investors.

The Company's 2018 Annual General Meeting will be held at 11.30am on 24 May 2019 at the offices of Osborne Clarke, One London Wall, London, EC2Y 5EB.

Ends

For further information:

Fevertree Drinks plc	+44 (0)20 7349 4922
Tim Warrillow, Co-founder and CEO
Andy Branchflower, Finance Director
Oliver Winters, Communications & IR Director
Numis Securities - Nominated Adviser and Joint Broker	+44 (0)20 7260 1000
Garry Levin
Matt Lewis
Hugo Rubinstein
Investec Bank plc - Joint Broker	+44 (0)20 7597 5970
David Flin
Alex Wright
David Anderson
Brunswick Group	+44 (0) 20 7404 5959
Jonathan Glass
Fiona Micallef-Eynaud
Cerith Evans

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On-Trade") as well as selected retail outlets ("Off-Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCGUGDSDUDBGCX